ASELAGE STEVE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed May 29, 2024
Insider Transaction Report
Form 4
ASELAGE STEVE
Director
Transactions
- Purchase
Common Stock
2024-05-24$6.40/sh+2,500$16,000→ 2,500 total(indirect: By Trust)
Holdings
- 63,339
Common Stock